Lin BioScience (ROCO:6696) Total Liabilities : NT$179.48 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Total Liabilities?

Lin BioScience's Total Liabilities for the quarter that ended in Jun. 2023 was NT$179.48 Mil.

Lin BioScience's quarterly Total Liabilities increased from Jun. 2022 (NT$72.52 Mil) to Dec. 2022 (NT$116.06 Mil) and increased from Dec. 2022 (NT$116.06 Mil) to Jun. 2023 (NT$179.48 Mil).

Lin BioScience's annual Total Liabilities declined from Dec. 2021 (NT$470.25 Mil) to Dec. 2022 (NT$116.06 Mil) but then increased from Dec. 2022 (NT$116.06 Mil) to Dec. 2023 (NT$167.73 Mil).

Lin BioScience Total Liabilities Historical Data

The historical data trend for Lin BioScience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Total Liabilities Chart

Lin BioScience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

105.97

308.87

470.25

116.06

167.73

Lin BioScience Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial										470.25	72.52	116.06	179.48	167.73

Lin BioScience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lin BioScience's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	138.704	+	(29.026	+	-1.7763568394003E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	167.73

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3596.722	-	3428.992
	=	167.73

Lin BioScience's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	142.967	+	(36.51	+	-7.105427357601E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	179.48

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	2198.307	-	2018.83
	=	179.48

Lin BioScience Total Liabilities Related Terms

Thank you for viewing the detailed overview of Lin BioScience's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience (ROCO:6696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110

Website

https://www.linbioscience.com

Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines